Pfizer CEO on outlook for monthly GLP-1 injection coming to market

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

Pfizer CEO Albert Bourla tells CNBC that the company’s GLP-1 drug could appeal to customers looking for a monthly injection, rather than weekly.